Published in J Emerg Trauma Shock on January 01, 2010
Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock. Am J Respir Crit Care Med (2011) 1.10
Gene expression profiles of immune mediators and histopathological findings in animal models of leptospirosis: comparison between susceptible hamsters and resistant mice. Infect Immun (2011) 0.99
Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit. Crit Care (2015) 0.90
Role of acute ethanol exposure and TLR4 in early events of sepsis in a mouse model. Alcohol (2011) 0.84
Commenting on biomarkers for differentiating between SIRS and sepsis. J Emerg Trauma Shock (2010) 0.83
Therapeutic efficacy of CXCR3 blockade in an experimental model of severe sepsis. Crit Care (2012) 0.82
Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department. PLoS One (2014) 0.81
Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis. Scand J Clin Lab Invest (2013) 0.81
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases. Diagnostics (Basel) (2015) 0.79
The role of CXCL10 in the pathogenesis of experimental septic shock. Crit Care (2014) 0.78
Predicting the outcomes for out-of-hospital cardiac arrest patients using multiple biomarkers and suspension microarray assays. Sci Rep (2016) 0.77
Authors's reply. J Emerg Trauma Shock (2010) 0.75
Viral and bacterial co-infection in severe pneumonia triggers innate immune responses and specifically enhances IP-10: a translational study. Sci Rep (2016) 0.75
Mass spectrometry for the discovery of biomarkers of sepsis. Mol Biosyst (2017) 0.75
Inflammatory molecules expression pattern for identifying pathogen species in febrile patient serum. Exp Ther Med (2016) 0.75
Polystyrene-Divinylbenzene-Based Adsorbents Reduce Endothelial Activation and Monocyte Adhesion Under Septic Conditions in a Pore Size-Dependent Manner. Inflammation (2016) 0.75
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (1994) 27.36
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med (1992) 20.79
Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature (1985) 9.18
Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res (2007) 2.41
A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J Exp Med (2000) 2.17
Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis (2006) 1.65
Activation of Paneth cell alpha-defensins in mouse small intestine. J Biol Chem (2001) 1.63
Matrix metalloproteinases: old dogs with new tricks. Genome Biol (2003) 1.59
Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med (2001) 1.41
IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res (2007) 1.35
Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J Immunol (2006) 1.29
Metabolic responses to cachectin/TNF. A brief review. Ann N Y Acad Sci (1990) 1.28
A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem (1999) 1.22
Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis (2003) 1.12
Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol (2007) 1.11
Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. Am J Physiol Heart Circ Physiol (2005) 1.01
Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains. Infect Immun (2008) 0.99
Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med (1997) 0.98
Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone. Int J Biol Sci (2007) 0.98
CCR4 is a key modulator of innate immune responses. J Immunol (2006) 0.95
Longitudinal course and clinical significance of TGF-beta1, sL- and sE-Selectins and sICAM-1 levels during severe acute stress in children. Clin Biochem (2007) 0.90
Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure. J Crit Care (2001) 0.87
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies. Clin Dev Immunol (2006) 0.85
Immunohistochemical expression of E-selectin in sepsis-induced lung injury. Int J Legal Med (2000) 0.83
sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome. Pediatr Res (2002) 0.82
Circulating levels of FAS/APO-1 in patients with the systemic inflammatory response syndrome. Diagn Microbiol Infect Dis (2003) 0.80
Vascular prosthetic implantation is associated with prolonged inflammation following aortic aneurysm surgery. J Artif Organs (2003) 0.79
Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem (2005) 4.18
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods (2007) 2.04
Expanding assay dynamics: a combined competitive and direct assay system for the quantification of proteins in multiplexed immunoassays. Clin Chem (2008) 1.97
Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis (2007) 1.78
A designed ankyrin repeat protein evolved to picomolar affinity to Her2. J Mol Biol (2007) 1.71
Protein microarray technology. Trends Biotechnol (2002) 1.68
Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J Immunol (2013) 1.57
Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care (2010) 1.56
Color loss in ethanolic solutions of chlorophyll a. J Agric Food Chem (2010) 1.40
Cellphone-based devices for bioanalytical sciences. Anal Bioanal Chem (2013) 1.37
Protein microarrays for diagnostic assays. Anal Bioanal Chem (2008) 1.35
Hemophagocytic lymphohistiocytosis and Kawasaki disease: combined manifestation and differential diagnosis. Pediatr Blood Cancer (2009) 1.31
Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis (2006) 1.28
Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients. BMC Surg (2010) 1.28
Protein microarrays: promising tools for proteomic research. Proteomics (2003) 1.27
Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4. Cell Microbiol (2005) 1.25
Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine (2008) 1.25
Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey. Crit Care (2007) 1.24
Protein microarray technology. Drug Discov Today (2002) 1.23
Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J Immunol (2005) 1.19
Inflammation-associated autophagy-related programmed necrotic death of human neutrophils characterized by organelle fusion events. J Immunol (2011) 1.15
Association of lipopolysaccharide-binding protein and coronary artery disease in men. J Am Coll Cardiol (2007) 1.14
Protein microarrays: applications and future challenges. Curr Opin Drug Discov Devel (2005) 1.10
Protein microarrays and multiplexed sandwich immunoassays: what beats the beads? Comb Chem High Throughput Screen (2004) 1.07
Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases. Med Eng Phys (2008) 1.05
Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis. Med Pediatr Oncol (2002) 1.05
Protein microarrays for personalized medicine. Clin Chem (2010) 1.03
Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation. Pediatrics (2006) 1.00
Sequential multiplex analyte capturing for phosphoprotein profiling. Mol Cell Proteomics (2010) 0.99
Association of adiponectin levels and insulin demand in critically ill patients. Diabetes Metab Syndr Obes (2011) 0.95
Protein microarrays: catching the proteome. Mech Ageing Dev (2005) 0.94
Multiplex microsphere-based flow cytometric platforms for protein analysis and their application in clinical proteomics - from assays to results. Electrophoresis (2009) 0.94
Severe bacteria-associated hemophagocytic lymphohistiocytosis in an extremely premature infant. Acta Paediatr (2007) 0.91
Microsphere-based co-immunoprecipitation in multiplex. Anal Biochem (2009) 0.91
Targeting peptide termini, a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identification. Mol Cell Proteomics (2010) 0.90
Protein microarray technology. Front Biosci (2002) 0.90
A dual array-based approach to assess the abundance and posttranslational modification state of signaling proteins. Sci Signal (2012) 0.90
Protein microarrays for antibody profiling: specificity and affinity determination on a chip. Proteomics (2005) 0.89
Proteome wide screening using peptide affinity capture. Proteomics (2009) 0.89
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. BMC Cancer (2012) 0.89
Bacterial reprogramming of PBMCs impairs monocyte phagocytosis and modulates adaptive T cell responses. J Leukoc Biol (2012) 0.88
Secretion of matrix metalloproteinase 3 by expanded articular chondrocytes as a predictor of ectopic cartilage formation capacity in vivo. Arthritis Rheum (2008) 0.88
Multiplexed immunoassays for the analysis of breast cancer biopsies. Anal Bioanal Chem (2010) 0.86
Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans. Shock (2010) 0.86
Miniaturized parallelized sandwich immunoassays. Methods Mol Biol (2008) 0.85
Role of ATP in trauma-associated cytokine release and apoptosis by P2X7 ion channel stimulation. Ann N Y Acad Sci (2006) 0.85
From spots to beads-PTM-peptide bead arrays for the characterization of anti-histone antibodies. Proteomics (2013) 0.84
µFBI: a microfluidic bead-based immunoassay for multiplexed detection of proteins from a µL sample volume. PLoS One (2010) 0.84
K-antigen-specific, but not O-antigen-specific natural human serum antibodies promote phagocytosis of Klebsiella pneumoniae. FEMS Immunol Med Microbiol (2003) 0.84
Protein microarrays: effective tools for the study of inflammatory diseases. Methods Mol Biol (2009) 0.83
Crystallization and dissolution behavior of naproxen/polyethylene glycol solid dispersions. J Phys Chem B (2013) 0.83
Snapshots of protein dynamics and post-translational modifications in one experiment--beta-catenin and its functions. Mol Cell Proteomics (2011) 0.83
Pyrosequencing-based strategy for a successful SNP detection in two hypervariable regions: HV-I/HV-II of the human mitochondrial displacement loop. Electrophoresis (2010) 0.82
[Protein microarrays and personalized medicine]. Ann Biol Clin (Paris) (2011) 0.81
Advances in recombinant antibody microarrays. Clin Chim Acta (2004) 0.81
A rapid SNAP-tag fluorogenic probe based on an environment-sensitive fluorophore for no-wash live cell imaging. ACS Chem Biol (2014) 0.81
Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Int J Med Microbiol (2006) 0.81
Sepsis-Induced Adipokine Change with regard to Insulin Resistance. Int J Inflam (2012) 0.81
Cell microarrays: an emerging technology for the characterization of antibodies. Biotechniques (2002) 0.80
Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock. Cytokine (2002) 0.80
Antigen biochips verify and extend the scope of antibody detection in Lyme borreliosis. Diagn Microbiol Infect Dis (2007) 0.80
Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro. Mol Immunol (2012) 0.80
Complement activation during sepsis in humans. Adv Exp Med Biol (2006) 0.80
Soluble CD163: An age-dependent, anti-inflammatory biomarker predicting outcome in sepsis. Crit Care Med (2006) 0.79
A protein detection technique by using surface plasmon resonance (SPR) with rolling circle amplification (RCA) and nanogold-modified tags. Biosens Bioelectron (2006) 0.79
Protein-protein-interactions in a multiplexed, miniaturized format a functional analysis of Rho GTPase activation and inhibition. Proteomics (2010) 0.78
Biochip as a potential platform of serological interferon alpha2b antibody assay. J Biotechnol (2003) 0.78
Functional analysis of Rho GTPase activation and inhibition in a bead-based miniaturized format. Methods Mol Biol (2012) 0.77
Magnetic bead-based detection of autoimmune responses using protein microarrays. N Biotechnol (2009) 0.77
Receptor tyrosine kinase inhibitor profiling using bead-based multiplex sandwich immunoassays. Methods Mol Biol (2012) 0.77
G protein-coupled receptor quantification using peptide group-specific enrichment combined with internal peptide standard reporter calibration. J Proteomics (2013) 0.76
Superficial wound swabbing: a novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations. Diabetes Care (2012) 0.76
A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries. BMC Genomics (2008) 0.76
MAPkinase gene expression, as determined by microarray analysis, distinguishes uncomplicated from complicated reconstitution after major surgical trauma. Ann N Y Acad Sci (2006) 0.76
Microarray technology: an increasing variety of screening tools for proteomic research. Drug Discov Today (2004) 0.76
Phagocytosis and digestion of pH-sensitive fluorescent dye (Eos-FP) transfected E. coli in whole blood assays from patients with severe sepsis and septic shock. J Cell Commun Signal (2011) 0.76
Neuropeptide FF increases M2 activation and self-renewal of adipose tissue macrophages. J Clin Invest (2017) 0.76
A Miniaturized Ligand Binding Assay for EGFR. Int J Proteomics (2012) 0.75
Plasma matrix metalloproteinase 1, 3, and 7 levels and breast cancer risk in the Nurses' Health study. Cancer Causes Control (2014) 0.75
BK viremia in critically ill surgical patients with hemorrhagic or septic shock. BMC Res Notes (2012) 0.75
Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis. Mol Cell Proteomics (2012) 0.75
The long and difficult road to the diagnostic market: protein microarrays. Drug Discov Today (2006) 0.75
Authors's reply. J Emerg Trauma Shock (2010) 0.75
Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole blood. Int Immunopharmacol (2012) 0.75
Caspase-3 activation, Bcl-2 contents, and soluble FAS-ligand are not related to the inflammatory marker profile in patients with sepsis and septic shock. Ann N Y Acad Sci (2006) 0.75
Compact spectrometer system based on a gradient grating period guided-mode resonance filter. Opt Express (2016) 0.75